Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Pharmalot By Ed Silverman

Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate

The new bill would require the FDA and the Patent & Trademark Office to create a task force that boosts coordination between the two.

Read The Story

Pharma By Jessica Davis Plüss

European researchers seek greater stake in drug development in bid to improve access

Pharmalot By Ed Silverman

Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy

Pharmalot By Ed Silverman

FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

Exclusive By Ed Silverman

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Pharmalot By Ed Silverman

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

Pharmalot By Ed Silverman

European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market

Pharmalot By Ed Silverman

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: FTC warns pharma and PBMs about rebate schemes; WTO reaches Covid vaccine patent waiver deal

Pharmalot By Ed Silverman

WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy

Pharmalot By Ed Silverman

Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results

Pharma By Adam Feuerstein

A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease

Health By Akila Muthukumar

Popular drug may have new benefit in men with diabetes, but not women, study shows

Pharmalot By Ed Silverman

Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries

Pharmalot By Ed Silverman

FDA oversight of pharma manufacturing facilities plunges during the pandemic

Pharmalot By Ed Silverman

In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries

Pharmalot By Ed Silverman

Pharmalittle: Lawmakers urge FTC to probe blood thinner prices; EU pressures Covid vaccine makers to renegotiate contracts

Pharmalot By Ed Silverman

A widely anticipated ALS drug wouldn’t be cost effective if priced the same as an older rival

FDAApprovalPt2_Illustration_MollyFerguson_041222

Pharmalot By Ed Silverman

Quantity over quality: FDA approved more cancer drugs than EMA, but they may not have always benefited patients

Pharmalot By Ed Silverman

Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire

Pharmalot By Ed Silverman

Simmering disputes persist as Covid patent waiver talks come down to the wire

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

First Opinion By Thomas B. Cueni

Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity

Pharmalot By Ed Silverman

Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results

Pharmalot By Ed Silverman

Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years

Pharmalot By Ed Silverman

How high? Prices for newly launched medicines rose 20% annually, analysis finds

Pharmalot By Ed Silverman

Senate lawmakers introduce a bill to help the FDA and the U.S. Patent Office coordinate

European researchers seek greater stake in drug development in bid to improve access

Medicare could have saved billions on drugs if it paid what Mark Cuban charges at his new pharmacy

FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes

A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

All Coverage

Pharmalittle: U.K. inks $1.2 billion deal with Moderna for vaccine center; Top Biocon exec arrested in bribery scandal

Pharmalittle: Medicare could have saved billions if it paid what Cuban charges; India’s drug controller accused of taking bribe

European Commission investigates Vifor for ‘disparaging’ its only rival in iron deficiency market

Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs

Up and down the ladder: The latest comings and goings

Pharmalittle: FTC warns pharma and PBMs about rebate schemes; WTO reaches Covid vaccine patent waiver deal

WTO reaches a deal on Covid vaccine patent waivers, but industry and advocates remain unhappy

Pharmalittle: CVS whistleblower suit details plans to boost consumer drug costs; Roche reports negative Alzheimer’s trial results

A Roche treatment fails to slow cognitive decline in patients with inherited form of Alzheimer’s disease

Popular drug may have new benefit in men with diabetes, but not women, study shows

Pharmalittle: FDA panel to review Covid shots for young children; Shionogi to license antibiotic to dozens of poor countries

FDA oversight of pharma manufacturing facilities plunges during the pandemic

In a first-of-its-kind deal, major drugmaker licenses antibiotic production for low-income countries

Pharmalittle: Lawmakers urge FTC to probe blood thinner prices; EU pressures Covid vaccine makers to renegotiate contracts

A widely anticipated ALS drug wouldn’t be cost effective if priced the same as an older rival

Quantity over quality: FDA approved more cancer drugs than EMA, but they may not have always benefited patients

Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire

Simmering disputes persist as Covid patent waiver talks come down to the wire

Up and down the ladder: The latest comings and goings

Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity

Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results

Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years

How high? Prices for newly launched medicines rose 20% annually, analysis finds

Pharmalittle: FDA panel endorses Novavax Covid shot; FTC to probe pharmacy benefit managers

Subscribe to STAT for $15 per month lorem ipsum